Skip to main content
. 2015 May 22;17(1):134. doi: 10.1186/s13075-015-0630-5

Figure 1.

Figure 1

Inclusion and exclusion of patients in the study. aba, abatacept; rit, rituximab; TNF, Tumour necrosis factor; TNFi, Tumour necrosis factor inhibitor; toc, tocilizumab.